Numantec / News
News
With a focus on innovation and the strengthening of a sector that is constantly growing and evolving, NUMANTEC was established—a new biomedical group composed of various entities specialized in healthcare assistance solutions.
Numantec Announces Completion of Investment from Goldman Sachs Alternatives
Viadana, 17th November 2026 – Today Numantec (the “Company”), a leading developer, manufacturer and distributor of infusion medical devices, announced...
GAVeCeLT 2026: Numantec at the Congress Dedicated to Vascular Access
The Numantec Group will attend the 2026 GAVeCeLT National Congress, taking place in Rome from 1 to 3 December. The...
From 16 to 19 November 2026, the Numantec Group will be in Düsseldorf for MEDICA and COMPAMED, two of the...
Vascular access management has traditionally been associated with the hospital setting, where specialised staff, dedicated devices and appropriate equipment are...
Large-Capacity Syringes: Features and Selection Criteria
Large-capacity syringes are used in procedures that involve handling larger volumes of fluid than those typically managed with smaller syringes....
Patient-Centred Care: How It Guides Vascular Access Selection
The choice of vascular access is necessarily based on clinical criteria: type and duration of therapy, venous access, infusion characteristics,...
Numantec at the 2nd SIAV National Congress in Vicenza
On 15 and 16 October 2026, Numantec will attend the 2nd SIAV National Congress – Italian Society for Vascular Access...
Healthcare Professional Training in Vascular Access Management
Vascular access management is part of many care pathways and requires skills ranging from device selection to its correct management...
Peripheral Venous Catheters: From Long Cannulas to Midlines
Peripheral venous catheters include devices with different lengths and characteristics, allowing access to be adapted to venous conditions, the expected...
